$31.64 $0.48 (1.5%)

04:30 PM EDT on 04/18/19

Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 3 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Current Price $31.64 Mkt Cap $455.3M
Open $31.00 P/E Ratio 0.00
Prev. Close $31.16 Div. (Yield) -$99,999.99 (0.0%)
Daily Range $30.98 - $31.67 Volume 46,189
52-Wk Range $29.08 - $40.65 Avg. Daily Vol.

Caps

How do you think NASDAQ:ANIK will perform against the market?

Add Stock to CAPS Watchlist

All Players

252 Outperform
8 Underperform
 

All-Star Players

28 Outperform
2 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:ANIK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

staylo2561 (< 20)
Submitted March 11, 2014

The new approved drug is based on HRA, and is a one injection shot to the knee for osteoarthritis. I have taken HRA for years....It is a miracle drug.

tunstavurn (< 20)
Submitted March 02, 2011

Pending lawsuit with genzyme.declining marginsIncreased competition

NASDAQ:ANIK VS S&P 500 (SPY)

Fools bullish on NASDAQ:ANIK are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ANIK.

Recs

0
Member Avatar wstanislaw (33.97) Submitted: 7/7/2015 6:15:01 PM : Outperform Start Price: $32.57 NASDAQ:ANIK Score: -43.21

Great financials, zero debt, under valued based on growth history and potential. High demand got content arthritis treatment and a growing market if baby boomers will expand that demand. More potential in European and global markets, and existing foreign subsidiaries.

Recs

0
Member Avatar healthcarevalue (85.31) Submitted: 3/31/2015 6:43:30 PM : Outperform Start Price: $41.18 NASDAQ:ANIK Score: -63.68

ANIK - Anika Therapeutics Inc. - negligible to zero debt/equity ratio. Return on Invested Capital (ROIC) = 24.43 TTM. Price/earnings ratio of 16.4 TTM is reasonable. Niche biotech healthcare industry company specializing in therapeutic products for tissue repair and multiple different treatments in increasing demand by baby boomers.

Recs

0
Member Avatar puneetkataria (< 20) Submitted: 3/1/2015 1:47:37 AM : Outperform Start Price: $39.96 NASDAQ:ANIK Score: -58.41

Great fundamentals and a huge market for the products.

Leaderboard

Find the members with the highest scoring picks in ANIK.

Score Leader

zebradave

zebradave (65.69) Score: +1,020.27

God be with you.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mechming < 20 12/7/2010 Outperform 5Y $5.53 +472.15% +133.98% +338.17 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. acts20 55.97 9/30/2011 Outperform NS $5.41 +484.84% +151.95% +332.89 2 Comments
siri22 < 20 9/1/2011 Outperform NS $6.00 +427.33% +137.14% +290.19 1 Comment
vin100r < 20 8/12/2011 Outperform 3W $6.05 +422.98% +144.93% +278.04 0 Comment
germantownrockvi < 20 12/14/2010 Outperform 5Y $6.20 +410.32% +132.46% +277.86 0 Comment
danculbertson 58.14 8/10/2010 Outperform 5Y $5.90 +436.27% +158.86% +277.41 0 Comment
cerroalegre 27.54 12/15/2010 Outperform 5Y $6.34 +399.05% +133.04% +266.01 0 Comment
mechincl < 20 10/25/2010 Outperform 5Y $6.33 +399.84% +143.41% +256.43 0 Comment
gsabc 73.39 6/25/2010 Outperform 5Y $6.16 +413.64% +169.17% +244.47 1 Comment
5starman 60.88 6/1/2011 Outperform 5Y $7.09 +346.26% +117.28% +228.99 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.97 10/28/2016 Outperform 3W $43.00 -26.42% +36.44% -62.86 0 Comment
TrackWayneRogers 61.70 11/29/2013 Outperform 3M $34.35 -7.89% +60.22% -68.11 0 Comment
tracksummerstree 89.72 9/19/2011 Outperform NS $5.72 +453.15% +143.47% +309.67 0 Comment
TrackNCPI < 20 11/7/2007 Outperform NS $14.86 -74.29% -47.61% -26.68 12/1/2008 @ $3.82 0 Comment

Advertisement